Evidence map›Paper›PMID 26424619›Full record

ArticleJournal of virological methods2015

Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.

Eri Nakatani-Webster, Shiu-Lok Hu, William M Atkins, Carlos Enrique Catalano

Abstract read
In one paragraph

Article in Journal of virological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Covalently circularized nanodiscs; challenges and applications.Current opinion in structural biology · 2018
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eri Nakatani-WebsterDepartment of Medicinal Chemistry, School of Pharmacy, University of Washington, H-172 Health Sciences Building, Box 357610, Seattle, WA 98195, United States.
Shiu-Lok HuDepartment of Pharmaceutics, School of Pharmacy, University of Washington, H272 Health Sciences Building, Box 357610, Seattle, WA 98195, United States.
William M AtkinsDepartment of Medicinal Chemistry, School of Pharmacy, University of Washington, H-172 Health Sciences Building, Box 357610, Seattle, WA 98195, United States.
Carlos Enrique CatalanoDepartment of Medicinal Chemistry, School of Pharmacy, University of Washington, H-172 Health Sciences Building, Box 357610, Seattle, WA 98195, United States. Electronic address: catalanc@uw.edu.
University of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Oral immunization against HIV/AIDS with prime-boost strategiesR01DE021223 · NIDCR · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 2011 to 2015
$3.1M
Biochemical and Biophysical Characterization of HIV Env Trimer Spikes using NanodR21AI087487 · NIAID · UNIVERSITY OF WASHINGTON · PI CATALANO, CARLOS ENRIQUE · 2010 to 2011
$413k
NIAID NIH HHS R21 AI087487NIDCR NIH HHS #R01 DE021223NIDCR NIH HHS R01 DE021223NIH HHS P51 OD010425PHS HHS #OPP1033102
6 · The paper itself

Abstract

The human immunodeficiency virus (HIV) is the causative agent of acquired immune deficiency syndrome (AIDS) and is thus responsible for significant morbidity and mortality worldwide. Despite considerable effort, preparation of an effective vaccine for AIDS has been elusive and it has become clear that a fundamental understanding of the relevant antigenic targets on HIV is essential. The Env trimer spike is the only viral antigen present on the surface of the viral particle and it is the target of all broadly neutralizing antibodies isolated to date. Thus, a soluble, homogeneous, and well-defined preparation of Env trimers is an important first step toward biochemical and structural characterization of the antigenic spike. Phospholipid bilayer nanodiscs represent a relatively new technology that can serve as a platform for the assembly of membrane proteins into a native membrane-like environment. Here we describe the preparation and characterization of unprocessed full-length, natively glycoslyated gp160 Env proteins incorporated into nanodiscs (gp160-ND). The particles are soluble and well defined in the absence of detergent, and possess a morphology anticipated of Env incorporated into a lipid ND. Importantly, the gp160-NDs retain CD4 and Env antibody binding characteristics expected of a functional trimer spike and their incorporation into a lipid membrane allows interrogation of epitopes associated with the membrane-proximal ectodomain region of gp41. These studies provide the groundwork for the use of gp160-ND in more detailed biochemical and structural studies that may set the stage for their use in vaccine development.

Indexed as

AIDS VaccinesAntibodies, NeutralizingHIV Envelope Protein gp160HIV InfectionsHumansNanoparticlesAIDS VaccinesAntibodies, NeutralizingHIV Envelope Protein gp160AIDSEnvGlycoproteingp160HIVLipid nanodiscsMembrane protein

Identifiers

PMID26424619
PMCPMC4633331
OpenAlexW1750227097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.